Correspondence 0001193125-25-070447 from Forte Biosciences, Inc. (FBRX)
Forte Biosciences, Inc.
Date: April 1, 2025 · CIK: 0001419041 · Accession: 0001193125-25-070447
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-286226
Letter
Re: Forte Biosciences, Inc. Registration Statement on Form S-3 File No. 333-286226 Acceleration Request Requested Date: April 3, 2025 Requested Time: 4:00 P.M. Eastern Time Ladies and Gentlemen: Pursuant to Rules 460 and 461 under the Securities Act of 1933, as amended, Forte Biosciences, Inc. (the “ Company ”) hereby requests that the above-referenced Registration Statement on Form S-3 (File No.333-286226) (the “ Registration Statement ”) be declared effective at the “Requested Date” and “Requested Time” set forth above, or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Dan Koeppen at (858) 350-2393 or via email at dkoeppen@wsgr.com .
April 1, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549-3720 Attn: Daniel Crawford
Sincerely,
FORTE BIOSCIENCES, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP April 1, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549-3720 Attn: Daniel Crawford Re: Forte Biosciences, Inc. Registration Statement on Form S-3 File No. 333-286226 Acceleration Request Requested Date: April 3, 2025 Requested Time: 4:00 P.M. Eastern Time Ladies and Gentlemen: Pursuant to Rules 460 and 461 under the Securities Act of 1933, as amended, Forte Biosciences, Inc. (the “ Company ”) hereby requests that the above-referenced Registration Statement on Form S-3 (File No.333-286226) (the “ Registration Statement ”) be declared effective at the “Requested Date” and “Requested Time” set forth above, or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Dan Koeppen at (858) 350-2393 or via email at dkoeppen@wsgr.com . Sincerely, FORTE BIOSCIENCES, INC. /s/ Paul A. Wagner, Ph.D. Paul A. Wagner, Ph.D. Chief Executive Officer cc: Dan Koeppen, Wilson Sonsini Goodrich & Rosati, P.C. Ben Capps, Wilson Sonsini Goodrich & Rosati, P.C.